Analysis of genetic polymorphisms related to drug metabolism
The mass array method allows for the simultaneous analysis of multiple genetic polymorphisms.
There are individual differences in drug metabolism activity, and these differences are believed to be due to genetic polymorphisms. In the field of pharmacogenomics (PGx), there is an expectation for the application of personalized medicine that takes into account the effects of drugs, side effects, and drug interactions by investigating genetic polymorphisms. This document introduces the analysis of genetic polymorphisms related to drug metabolism using a designed analysis tool based on mass array methods. Genetic polymorphisms will be determined from the analysis results of SNPs (Single Nucleotide Polymorphisms) and CNVs (Copy Number Variations) for 20 drug metabolism-related genes.
- 企業：一般財団法人材料科学技術振興財団 MST
- 価格：Other
